Main menu

Oncology

Improving the care of patients with metastatic renal cell carcinoma (mRCC) via a patient and provider intervention program.

Organization:

The Research Institute of Fox Chase Cancer Center

Project Lead:

Dr. Daniel Geynisman

Improving the care of patients with metastatic renal cell carcinoma (mRCC) via a patient and provider intervention program.

We propose to address those gaps in a large oncology community network via an educational intervention and virtual tumor board for providers and an electronic self-reported assessment portal for patients.

Aim 1 is to develop, implement and evaluate an ongoing educational series of didactic and case-based presentations for oncology providers (MDs, NPs, PAs, RNs) focusing on the primary challenges of treating mRCC: appropriate prognostication and selection of drugs for a given line of therapy, adverse event management, adherence to oral agents, decisions of when to switch or escalate/de-escalate therapy, QOL assessments and appropriate integration of surgical and radiation therapy.

Aim 2 is to develop, implement and evaluate a sustainable on-line patient self-reported assessment portal to improve patient-provider communication, patient disease management and QOL and the management of therapy-related side-effects.

Aim 3 is to operationalize and implement a virtual tumor board for community oncologists to be able to interact on a regular basis with an academic medical center's genitourinary (GU) experts.

Full Proposal Interim Reports Final Report
PDF []

Approval Date:

April 2014

Amount Awarded:

$258,206.00

Start Date:

05/01/2014

End Date:

04/30/2016

Status:

In Progress

RFP:

Community Oncologist Education and Support Systems - Renal Cell Carcinoma and Hematologic Malignancies

RFP ID:

2013ON2